Human medicines European public assessment report (EPAR): Hetlioz, tasimelteon, Date of authorisation: 03/07/2015, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Adcetris, brentuximab vedotin, Date of authorisation: 25/10/2012, Revision: 37, Status: Authorised

Veterinary Scientific Advice procedure – timelines 2026 - information for applicants

Human medicines European public assessment report (EPAR): Lynparza, olaparib, Date of authorisation: 16/12/2014, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Sunitinib Accord, sunitinib, Date of authorisation: 11/02/2021, Revision: 4, Status: Authorised

Dengvaxia : EPAR - All authorised presentations

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 23, Status: Authorised

Website outages and upgrades

First EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 November 2025, 09:00 (CET) to 5 November 2025, 17:00 (CET)

Human medicines European public assessment report (EPAR): Tryngolza, olezarsen, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised